2021 Committees

Program Committees

Advertising and Promotion Conference Planning Committee helps FDLI to provide timely and relevant programming regarding advertising and promotion trends, emerging issues, and policy developments. This conference is typically held in the fall.

  • Melissa Scales (Staff Liaison), FDLI
  • Madhavi Bellamkonda, (Co-Chair), Abbott Laboratories
  • Rebecca Burnett, Framework Solutions
  • Julie B. Chronis, Gilead Sciences, Inc.
  • Mary Ellen Dronitsky, Northeastern University
  • Virginia Foley, Opus Regulatory, Inc.
  • Mark Gaydos, Sanofi
  • Bryant M. Godfrey, (Co-Chair), Foley Hoag LLP
  • Matthew Hegreness, Covington & Burling LLP
  • Mark Levy, Eckert Seamans Cherin & Mellott, LLC
  • Lauren A. Miller, AbbVie
  • Thomas Miller, Nixon GWILT Law
  • Gillian M. Russell, King & Spalding LLP
  • Victoria Tamarkin, Tamarkin Consulting LLC
  • Kyle Thomson, American Medical Association
  • Ashley Zborowsky, Medtronic

Annual Conference Planning Committee helps plan and implement FDLI’s Annual Conference, the premier event of the food and drug law community. This conference is typically held in the spring.

  • Laura Brown (Staff Liaison), FDLI
  • Wade Ackerman, Covington & Burling LLP
  • David J. Bloch, Medtronic
  • Jeffrey B. Chasnow, Pfizer, Inc.
  • Sandra B. Eskin, Pew Charitable Trusts
  • Todd Halpern, GlaxoSmithKline
  • Erika F. Lietzan, (Co-Chair), University of Missouri-Columbia School of Law
  • Eric N. Lindblom, Georgetown University
  • Adora Ndu, BioMarin Pharmaceutical Inc.
  • Meredith Q. Olearchik, Campbell Soup Company
  • Beth G. Oliva, Fox Rothschild
  • Suzan Onel, Kleinfeld, Kaplan & Becker LLP
  • John M. Packman, DLA Piper LLP
  • Stuart M. Pape, (Co-Chair), Polsinelli
  • Veleka Peeples-Dyer, Baker McKenzie
  • Vernessa T. Pollard, McDermott Will & Emery
  • David C. Spangler, Consumer Healthcare Products Association
  • Marta L. Villaraga, Exponent, Inc.
  • Anne K. Walsh, Hyman, Phelps & McNamara, PC

California Programs Planning Committee helps FDLI identify pertinent topics and develop programming to be offered in California.

  • Khara Minter (Staff Liaison), FDLI
  • Afia Asamoah, Google Health
  • Alecia Cotton, Rogers, Joseph, O’Donnell, P.C.
  • Vinita Kailasanath, Arnold & Porter LLP
  • Abby Meyer, Sheppard Mullin Richter & Hampton LLP
  • Natalie Rainer, Keller and Heckman LLP
  • Amy Speros, Latham & Watkins LLP
  • Deborah Tolomeo, Genentech, Inc.

Enforcement, Litigation, and Compliance Conference Planning Committee helps FDLI cover the latest trends and changes in enforcement and compliance. This conference is typically held in the fall.

  • Laura Brown (Staff Liaison), FDLI
  • Hannah R. Bornstein, Nixon Peabody LLP
  • Adrienne Franco Busby, Faegre Drinker Biddle & Reath LLP
  • Philip Crooker, Parexel International Corporation
  • Maya Florence, Skadden, Arps, Slate, Meagher & Flom LLP
  • Elizabeth A. Gallenagh, Healthcare Distribution Alliance (HDA)
  • William Gould, Holland & Knight LLP
  • Dennis C. Gucciardo, Morgan, Lewis & Bockius LLP
  • Stephanie M. Haggerty, Pfizer, Inc.
  • Bryan M. Haynes, Troutman Pepper Hamilton Sanders LLP
  • Winston S. Kirton, Winston & Strawn LLP
  • Peter J. Leininger, King & Spalding LLP
  • Donnelly McDowell, Kelley Drye & Warren LLP
  • Anne K. Miller, Medtronic
  • John A. Murphy III, Biotechnology Innovation Organization
  • Ann Oxenham, FDA
  • Bob Rhoades (Chair), Validant
  • Allen Sayler, EAS Consulting Group
  • Lora J. Spencer, Reed Smith LLP
  • William Stellmach, Willkie Farr & Gallagher LLP
  • Frances Zipp, Lachman Consultants

Food Advertising, Labeling, and Litigation Conference Planning Committee helps FDLI to provide updates on the most pertinent aspects and trends in advertising, labeling, and litigation. This conference is typically held in the fall.

  • Steven Leslie (Staff Liaison), FDLI
  • William C. Acevedo, Wendel Rosen LLP
  • Matthew G. Ball, K&L Gates LLP
  • Christopher Cole, Crowell & Moring LLP
  • Stefanie Jill Fogel, DLA Piper LLP (US)
  • Lorie Foster, Abbott Nutrition
  • Dale J. Giali, Mayer Brown LLP
  • August Horvath, Foley Hoag LLP
  • Samuel D. Jockel, Alston & Bird LLP
  • Maia Kats, Kaplan Fox & Kilsheimer LLP
  • Karin F. R. Moore, Hyman, Phelps & McNamara, PC
  • Megan L. Olsen, Council for Responsible Nutrition
  • Michael T. Roberts, UCLA School of Law
  • Christopher Van Gundy, Sheppard Mullin Richter & Hampton LLP
  • Kurt Weaver, Womble Bond Dickinson (US) LLP
  • Nury H. Yoo, Keller and Heckman LLP

Food and Dietary Supplements Safety and Regulation Conference Planning Committee helps FDLI cover recent developments and looming challenges for product safety and regulation. The conference is typically held in the Spring

  • Steve Leslie (Staff Liason), FDLI
  • Steve Armstrong, Haynes and Boone, LLP
  • Ricardo Carvajal, Hyman, Phelps & McNamara, PC
  • Jacqueline J. Chan, Kleinfeld, Kaplan & Becker, LLP
  • Elizabeth Barr Fawell, Hogan Lovells US LLP
  • Andrea G. Ferrenz, Campbell Soup Company
  • Neal Fortin, Michigan State University College of Law
  • Ryan Gooley, Stericycle
  • Elizabeth (Beth) Johnson, Food Directions LLC
  • Jensen Jose, Center for Science in the Public Interest
  • Heili Kim, Faegre Drinker Biddle & Reath LLP
  • Sarah Roller, Kelley Drye & Warren LLP

New to Food and Drug Law Planning Committee assists FDLI in creating educational programming and networking opportunities for those new to food and drug law.

  • Tess Garraty (Staff Liaison), FDLI
  • Alexander V. Alfano, Axinn, Veltrop & Harkrider LLP
  • Brigid Bondoc, Sidley Austin LLP
  • Lauren A. Farruggia, Goodwin Procter LLP
  • Rachel Goeriz, Exponent, Inc.
  • Steven Gonzalez, Ropes & Gray LLP
  • Maria Kalousi-Tatum, Morgan, Lewis & Bockius LLP
  • Anton Lesaca, Venable LLP
  • Stacey Pine, American Beverage Association
  • Matthew Piscitelli, Buchanan Ingersoll & Rooney PC
  • Daniel Stallone, Town of Davie Florida
  • Marc Wagner, BakerHostetler
  • Justin Waldrep, Sugaright
  • Jeanne Sun, U.S. Pharmacopeia

Patient Organization Engagement Committee assists FDLI by creating innovative introductory course offerings for patient organizations.

  • Paige Samson (Staff Liaison), FDLI
  • David M. Fox, Hogan Lovells US LLP
  • Ryan M. Hohman, Friends of Cancer Research 
  • Debra R. Lappin, Faegre Drinker Biddle & Reath LLP
  • Peter Pitts, Center for Medicine in the Public Interest
  • Kristin Schneeman, FasterCures
  • Deborah M. Shelton, Arent Fox LLP
  • Ami E. Simunovich, Becton Dickinson (BD)
  • Joshua Soreth-Harman, Sanofi
  • Kathryn Spates, The Joint Commission
  • Eva Temkin, King & Spalding

Webinar Programs Committee advises FDLI in formulating and implementing webinars about law, regulation and policy affecting food and dietary supplements, tobacco and nicotine, and medical products.

  • Melissa Scales (Staff Liaison), FDLI
  • Khara Minter (Staff Liaison), FDLI
  • Jerry W. Appert, Compliance Architects LLC
  • Kalah Auchincloss, Greenleaf Health, Inc
  • Nathan A. Beaver, Foley & Lardner LLP
  • Mitchell Berger, FDA – CBER
  • Jacqueline R. Berman, Morgan, Lewis & Bockius LLP
  • Vanessa K. Burrows, Simpson Thacher & Bartlett
  • Monica Groat, Latham & Watkins LLP
  • Elizabeth Guo, FDA – OC
  • Mark Hendrickson, Leavitt Partners, LLC
  • Lori F. Hirsch, Bristol-Myers Squibb Company
  • Thomas Lynch, Fortive Corporation
  • Brian Malkin, McDermott Will & Emery
  • Serra J. Schlanger, Hyman, Phelps & McNamara, PC
  • George Serafin, FTI Consulting, Inc
  • Frank Spano, Polsinelli PC
  • Steven S. Tjoe, Goodwin Procter LLP
  • Suzie Trigg, Haynes and Boone LLP
  • Leonel Vanegas, San Diego State University
  • Cicely Vaughn, Walmart Inc

Publications Committees

Austern Writing Awards Committee fosters the next generation of professionals in the food and drug law field.

  • Paige Samson (Staff Liaison), FDLI
  • Khelin N. Aiken, Baker McKenzie
  • Nathan Beaton, Latham & Watkins LLP
  • Barbara Binzak Blumenfeld, Buchanan Ingersoll & Rooney PC
  • Christopher Fanelli, Hogan Lovells US LLP
  • Joshua Oyster, Ropes & Gray LLP
  • Jordan Paradise, Loyola University
  • Mital Patel, Foley Hoag LLP
  • Melissa Runsten, Debevoise & Plimpton LLP
  • Mariam Sarwar, Crowell & Moring LLP

Food and Drug Law Journal Editorial Advisory Board provides peer review of manuscript submissions, advises on content, and serves as a resource for our student editors at Georgetown University Law Center.

  • Paige Samson (Staff Liaison), FDLI
  • Laurie Beyranevand, Vermont Law School
  • Jennifer Black, FDA – OC
  • Marie Boyd (Chair), University of South Carolina
  • Nathan Brown, Akin Gump Strauss Hauer & Feld LLP
  • Christine P. Bump, Penn Avenue Law & Policy
  • Jonathan M. Cohen, K&L Gates LLP
  • Bridget C. E. Dooling, George Washington University
  • Javier González-Rivera, Campaign for Tobacco-Free Kids
  • Lewis A. Grossman, American University
  • Peter Barton Hutt, Covington & Burling LLP
  • William M. Janssen, Charleston School of Law
  • John Johnson, Shook, Hardy & Bacon LLP
  • Alan C. Katz, toXcel, LLC
  • Sara Wexler Koblitz, Hyman, Phelps & McNamara, PC
  • Marian J. Lee, Gibson Dunn & Crutcher LLP
  • Priya Mannan, Novartis Pharmaceuticals Corporation
  • Eileen McMahon, Torys LLP
  • Cynthia L. Meyer, Kleinfeld, Kaplan & Becker, LLP
  • J.R. McNair, Winston & Strawn LLP
  • Alan Minsk, Arnall Golden Gregory LLP
  • Anne Marie Murphy, Consumer Healthcare Products Association (CHPA)
  • James O’Reilly, University of Cincinnati
  • Daniel Orr, Thomson Reuters
  • Joseph Page (Academic Advisor), Georgetown University
  • Jessica Ringel, King & Spalding LLP
  • Tyler Scandalios, Greenberg Traurig, LLP
  • Marc Scheineson, Alston & Bird LLP
  • Shy Shorer, National Institutes of Health
  • Anna Sims, FDA – OC
  • Eric Solowey, Parexel International Corporation
  • Genevieve Spires, Buchanan Ingersoll & Rooney PC
  • Emily Wright, Pfizer Inc.
  • Paige Samson (Staff Liaison), FDLI
  • Kenita Barrow, Otsuka America Pharmaceutical, Inc.
  • Ralph Hall, University of Minnesota
  • Joanne Hawana, Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
  • Laurie Lenkel, FDA – OC
  • Elizabeth Richards, Latham & Watkins LLP

Publications Peer Review Committee provides manuscript review and editorial feedback for Update magazine, electronic resources, and book chapters.

  • Paige Samson (Staff Liaison), FDLI
  • David Abramowitz, Locke Lord LLP
  • Alena Allen, University of Memphis
  • Daren Bakst, The Heritage Foundation
  • Royce DuBiner, McGuireWoods LLP
  • Ben Firschein
  • Jonathan Gil, Pfizer Inc.
  • R. Frederic Henschel, Potomac Law Group
  • Emily Hussey, Reed Smith LLP
  • Victor Krauthamer, George Washington University
  • Areta Kupchyk, Foley Hoag LLP
  • Justine Lenehan, Kleinfeld, Kaplan & Becker, LLP
  • T. Daniel Logan, Kleinfeld, Kaplan & Becker, LLP
  • Brandon Moss, Wiley Rein LLP
  • Jarred L. Reiling, King & Spalding LLP
  • Stephanie Resnik, Covington & Burling LLP
  • David Simon, George Washington University Law School
  • Andrew Wasson, Haug Partners LLP

Product Area Committees

Cannabis-Derived Products Committee assists FDLI with developing content and identifying stakeholders to contribute to the discussion of cannabis-derived products in the federal regulatory space.

  • Melissa Scales (Staff Liaison), FDLI
  • Karen Balderama, Wendel Rosen LLP
  • Tina Beamon, Karyopharm Therapeutics
  • Rodney Butt, Nutrasource Pharmaceutical & Nutraceutical Services
  • Katherine Ciambrone
  • Tara Lin Couch, EAS Consulting Group
  • Delia Ann Deschaine, Epstein Becker & Green, PC
  • Samantha Dietle, Hogan Lovells US LLP
  • William Garvin, Buchanan Ingersoll & Rooney PC
  • Kate Hardey, McGuireWoods LLP
  • Jonathan A. Havens, Saul Ewing Arnstein & Lehr LLP
  • Keith Matthews, Wiley LLP
  • Daniel McGee
  • Deborah Miran, DMiran Consulting
  • Heike Newman, University of Colorado
  • Daniel Charles Rubenstein, Steptoe & Johnson LLP
  • Juan Luis Serrano-Leets, Sánchez Devanny
  • Howard R. Sklamberg, Arnold & Porter LLP
  • Frederick A. Stearns, Keller and Heckman LLP
  • Justin M. L. Stern, Duane Morris LLP
  • Thomas Tobin, Perkins Coie LLP

Medical Products Committee helps FDLI provide programming to meet the needs of the medical products community.

  • Melissa Scales (Staff Liaison), FDLI
  • Roxana Aleali, Purdue Pharma L.P.
  • Nicholas Benetatos, Exponent, Inc.
  • Robert J. Berlin, GlaxoSmithKline
  • Mantej (Nimi) Chhina, BioMarin Pharmaceutical Inc.
  • Bryan J. Coleman, EAS Consulting Group
  • Jennifer Devine, U.S. Pharmacopeia
  • Brian Eckman, Genentech, Inc.
  • Lynne Ensor, Parexel International Corporation
  • Allison Fulton, Sheppard Mullin Richter & Hampton LLP
  • Margo Heath-Chiozzi, Celldex Therapeutics, Inc.
  • Colleen M. Heisey, Jones Day
  • Carmine Jabri, E.M.M.A. International Consulting Group, Inc.
  • Chad Landmon, Axinn, Veltrop & Harkrider LLP
  • Scott M. Lassman, Lassman Law + Policy
  • Gregory H. Levine, Ropes & Gray LLP
  • Davina R. Marano, FDA – CDRH
  • Christina Anderson Mooney, Medtronic
  • Lidia Niecko-Najjum, Crowell & Moring LLP
  • Sung Park, Reed Smith LLP
  • Schevon Gaylord Salmon, Otsuka America Pharmaceutical, Inc.
  • Kathleen M. Sanzo, Morgan, Lewis & Bockius LLP
  • Marinka Tellier, NSF International

Tobacco and Nicotine Products Committee ensures that tobacco programs bring diverse stakeholders together to have high-level discussions on tobacco products regulation and policy.

  • Steven Leslie (Staff Liaison), FDLI
  • Jasjit Ahluwalia, Brown University
  • Lindsay Andrews, JUUL Labs
  • Scott D. Ballin, Public Health Consultant
  • James Baumberger*, American Academy of Pediatrics
  • Aruni Bhatnagar*, University of Louisville
  • Azim Chowdhury, Keller and Heckman LLP
  • K. Michael Cummings, Medical University of South Carolina
  • Brittani Cushman, Turning Point Brands, Inc.
  • Clifford E. Douglas*, University of Michigan
  • Stacy Ehrlich, Kleinfeld, Kaplan & Becker, LLP
  • Stacey Gagosian, Truth Initiative
  • Thomas J. Glynn, Stanford University
  • Robyn Gougelet, Pinney Associates, Inc.
  • Dennis Henigan*, Campaign for Tobacco-Free Kids
  • Desmond Jenson*, Public Health Law Center – Tobacco Control Legal Consortium
  • Eshael M. Johnson, FDA – CTP
  • Rima Khoury, Fumari, Inc.
  • Ondrej Koumal, Philip Morris International
  • John Marshall, Altria Client Services LLC
  • Elizabeth Oestreich, Greenleaf Health, Inc.
  • John Pritchard, 22nd Century Group, Inc.
  • Agustin Rodriguez, Troutman Pepper Hamilton Sanders LLP
  • Henry Roemer, Finger, Roemer, Brown & Mariani LLP
  • Barry Schaevitz, Fox Rothschild LLP
  • Jim M. Solyst, Swedish Match North America
  • Mark J. Vaders, Womble Bond Dickinson (US) LLP
  • Benjamin K. Wolf, Alston & Bird LLP

* Public Health Subcommittee

  • Melissa Scales (Staff Liaison), FDLI
  • Neal Bataller, CVM, FDA
  • Grace Gowda, University of Georgia
  • Nancy E. Halpern, Fox Rothschild LLP
  • Kristin Kaplan, Shook, Hardy & Bacon LLP
  • Jeannie M. Perron, Covington & Burling LLP
  • Elizabeth B. Stutts, Hancock, Daniel & Johnson
  • Ashley Morgan, American Veterinary Medical Association

Governance Committees

Audit Committee oversees and evaluates the management’s control over financial reporting. This committee is led by and reports to the FDLI Board of Directors.

  • Hayley Carpenter (Staff Liaison), FDLI
  • Cathy L. Burgess (Chair), Alston & Bird LLP
  • Neil P. Di Spirito, Epstein Becker & Green, PC
  • Jonathan A. Havens, Saul Ewing Arnstein & Lehr LLP
  • Stuart M. Pape, Polsinelli PC

Black Lives Matter Advisory Group advises FDLI on substantive and programmatic issues relevant to diversity, equity, and inclusion with a focus on promoting greater representation of Black professionals in the food and drug law community.

  • Elizabeth H. Anderson, Anderson & Associates, LLC
  • Oluwaseun (Kemi) Asante, FDA – CDER
  • Shamina Aubuchon, Altria Client Services LLC
  • Alundai Benjamin, University of Connecticut
  • Jennifer L. Bragg, Skadden, Arps, Slate, Meagher & Flom LLP
  • Noni L. Ellison, Carestream Dental LLC
  • Iris Gibbs, Karyopharm Therapeutics
  • Melanie Katrice Gross, Greentech, Inc.
  • Janet Johnson, Terumo BCT, Inc.
  • Daniel A. Kracov, Arnold & Porter LLP
  • Anthony W. Lee, FDA – CFSAN
  • Valerie B. Marshall, FDA – CBER
  • Flora Chinyere Okereke, RAI Service Company (RAISC)
  • Sarah Thompson Schick, DLA Piper LLP (US)
  • LieAnn Van-Tull, Keller and Heckman LLP
  • Jeffrey N. Wasserstein, Hyman, Phelps & McNamara, PC
  • John (Barr) Weiner, FDA – OC
  • Patti Zettler, The Ohio State University

Finance Committee oversees FDLI’s financial affairs, including budget formulation and execution, and investment portfolio management. This committee is led by and reports to the FDLI Board of Directors.

  • Hayley Carpenter (Staff Liaison), FDLI
  • Frederick R. Ball (Chair), Duane Morris LLP
  • Jeffrey K. Francer (Board Liaison), Association for Accessible Medicines
  • Jeffrey N. Gibbs, Hyman, Phelps & McNamara, PC
  • Elizabeth Oestreich, Greenleaf Health, Inc.
  • Peter Pitts, Center for Medicine in the Public Interest
  • Stuart TenHoor, Stuart TenHoor Legal Search

Questions?

[email protected]
202-222-0910